Preparing for FDA Pre-Approval Inspections (ePub)

Name: Preparing for FDA Pre-Approval Inspections
Brand: Taylor & Francis
SKU: 128921574
Price: 79.49 EUR
Availability: OnlineOnly

A Guide to Regulatory Success, Second Edition (Sprache: Englisch)

Schreiben Sie einen Kommentar zu "Preparing for FDA Pre-Approval Inspections".

Merken

Mehr zum Inhalt Autorenporträt Video

Leider schon ausverkauft

Bestellnummer: 128921574

eBook (ePub) 79.49 €

Download bestellen

Verschenken

39 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Preparing for FDA Pre-Approval Inspections (ePub)“

This Second Edition is an essential guide to preparing for FDA pre-approval inspections-taking into account current trends in FDA expectations and inspection activities, such as the GMPs of the 21st Century, quality systems-based approach to inspections, risk-based inspections, quality by design, process analytical technology, design space, etc. The goal of this book is to help organizations gain rapid regulatory approval.

Autoren-Porträt

MARTIN D. HYNES III is Director of Product Research and Development and Six Sigma Champion at Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana. Dr. Hynes has authored or co-authored numerous scientific articles, abstracts, book chapters, books, and patents. He is a member of a number of scientific and industry organizations. He has spoken and served as session chair at meetings of these organizations on numerous occasions. Dr. Hynes earned his bachelor's degree in psychology from Providence College and his Ph.D. in pharmacology and toxicology from the University of Rhode Island. After completing a post-doctoral fellowship at the Roche Institute of Molecular Biology, he joined Lilly Research Labs. He has held several management positions, including Director of Pharmaceutical Project Management, Director of Quality Assurance, and Director for Clinical Research for Eli Lilly, Japan.